📣#Facilitate’s newsletter is out. Do not miss the latest news & next planned events ! Check it out and keep yourself updated!👉

🎉Here we are! Starting the #FACILITATE second General Assembly to be held today and tomorrow #15 December at the University of Bordeaux. @BxPharmacoEpi @univbordeaux

📣Do not miss tomorrow 31st of October the next #PEOF session where we'll discuss patient preferences on secondary use of their clinical trial data. Register here👉

#FACILITATE - Italy's pioneering Horizon IHI project - was unveiled during the HORIZON EUROPE 2024 WEEK at the National Info Day for research and innovation programs. Organized by APRE in collaboration with the @mur_gov_ #HorizonEU

Join us in the PEOF virtual session 'Building a framework for clinical trial participants' data reutilisation for a fully transparent and ethical ecosystem: IMI FACILITATE aims to address what patients want' on Tuesday #31October -14:30. Register here👉

@EUPATI_IT hosts a dissemination event for the #FACILITATE project addressed to their newly graduated Patient Experts in Drug Research and development, highlighting the need for more educated and informed citizens on this topic. 🎓🏥

RT @EUPATI_IT: 📷Domenica 15 Ottobre, a Roma, nell’ambito del week end di conclusione del corso #EUPATI, si svolgerà il #disseminationevent…

RT @Privanova_: @Imi_Facilitate was presented at the 6th Annual #SCOPEsummit for Clinical Ops Executives. #innovation #clinicaldata #healt…

🎉Today #FACILITATE was presented at the 6th Annual @SCOPEsummit for Clinical Ops Executives: As returning participant data helps establish trust in the research enterprise, facilitates partnerships and supports an individual's data ownership in making future care decision.

Now, in the USA, clinical trial participants can have reliable access to their individual data! The American experience of @pfizer is well explained in this article and it gives the exact context to what #FACILITATE is working on for Europe! Read more 👉

@Servier is a global pharmaceutical group governed by a Foundation.With a strong international presence in 150 countries and invests over 20% of revenue from brand-name medicines in R&D every year In #Facilitate will co-lead WP2/3/6👉 #IHI #patients

⁉️𝐖𝐡𝐚𝐭 𝐢𝐬 𝐅𝐀𝐂𝐈𝐋𝐈𝐓𝐀𝐓𝐄'𝐒 𝐎𝐕𝐄𝐑𝐀𝐋𝐋 𝐆𝐎𝐀𝐋? The overall goal of this 4years project is the development of a patient centered process prototype to allow the direct generation and the return of clinical trials data to study participants👉

We are proud to share that Farhan Sahito, @Privanova_ had the privilege of discussing #FACILITATE at the Fifth Intersessional Consultation of the Ad Hoc Committee, organised by the UN Office on Drugs and Crime in Vienna, from 20 to 21 June 2023. @UNODC

RT @Privanova_: @Privanova_ had an opportunity to participate in the Semi-Annual Meeting of @Imi_Facilitate in Paris on June 8th and 9th! 🚀…

FACILITATE’s project partners here together in #Paris for a Semi-annual meeting discussing how to return data to study participants & secondary use of these data! To be updated join #FACILITATE's pool of stakeholders here! 👉

⁉️𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐯𝐚𝐥𝐮𝐞𝐬 𝐨𝐟 𝐅𝐚𝐜𝐢𝐥𝐢𝐭𝐚𝐭𝐞 ? ✅Patients First; ✅Create a common space; ✅Remarkable Optimism; ✅Lead with Integrity; ✅A paradigm shifting endeavor. ...

Today is #InternationalClinicalTrialsDay and one of the aims of #Facilitate is to provide a prototype process for returning clinical trial data to study participants and to facilitate the conduct of health research projects, during and after the study. #ICTD2023

RT @Privanova_: 🔒This week, we celebrate #CybersecurityHealthcareWeek. @Privanova_ is proud to be part of groundbreaking projects, @Imi_Fa…

On 18 May,#EUPATIPT marks the #ClinicalTrialsDay, dedicated to the 'Space for Health Data'. Among the speakers Ana Vieira, one of the patient experts involved in #FACILITATE, will share the importance of returning data from individual clinical trials

RT @HKUCMEL: 📢 Governance of Medical #AI – Hong Kong, 9-11 May 2023 #DataGovernance and the FACILITATE Project: Defining the Elephant in t…